Neural Therapeutics Inc.

Neural Therapeutics Inc.

ISIN: CA64134N2032

June 12, 2026

Neural Therapeutics Announces AGSM Results, CFO Appointment and Welcomes Positive Developments in the German Cannabis Market

Toronto, Ontario, June 11, 2026 - Neural Therapeutics Inc. (CSE: NURL; Frankfurt: HANF) (“Neural” or the “Company”) is pleased to announce the results of its annual general and special meeting...
Read more >>

All NEWS OF Neural Therapeutics Inc.